SEC Form 4 · accession 0001013762-15-000926
DelMar Pharmaceuticals, Inc. · DMPI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeffrey Bacha
Officer — President, CEO · Director · 10% Owner
Period of report
Sep 18, 2015
Accepted (ET)
Sep 22, 2015 · 10:00 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001498382
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 18, 2015 | P | 4,000 | $0.83 | A | 127,485 | D |
Table II — derivative securities
No Table II lines on this filing.